These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11773884)

  • 1. Transplantation-induced endothelial dysfunction as studied in rat aorta allografts.
    Andriambeloson E; Pally C; Hengerer B; Cannet C; Nikolova Z; Bruns C; Zerwes HG; Bigaud M
    Transplantation; 2001 Dec; 72(12):1881-9. PubMed ID: 11773884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial dysfunction and denudation in rat aortic allografts.
    Andriambeloson E; Bigaud M; Schraa EO; Kobel T; Lobstein V; Pally C; Zerwes HG
    Arterioscler Thromb Vasc Biol; 2001 Jan; 21(1):67-73. PubMed ID: 11145935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete loss of functional smooth muscle cells precedes vascular remodeling in rat aorta allografts.
    Bigaud M; Schraa EO; Andriambeloson E; Lobstein V; Pally C; Kobel T; Bruns C; Zerwes HG
    Transplantation; 1999 Dec; 68(11):1701-7. PubMed ID: 10609946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplantation-induced functional/morphological changes in rat aorta allografts differ from those in arteries of rat kidney allografts.
    Andriambeloson E; Cannet C; Pally C; Klanke B; Bruns C; Zerwes HG; Bigaud M
    Am J Transplant; 2004 Feb; 4(2):188-95. PubMed ID: 14974939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-octanoyl Dopamine Attenuates the Development of Transplant Vasculopathy in Rat Aortic Allografts Via Smooth Muscle Cell Protective Mechanisms.
    Wedel J; Hottenrott MC; Bulthuis M; Huitema S; Yard BA; Hillebrands JL
    Transplantation; 2016 Jan; 100(1):80-90. PubMed ID: 26674731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporine treatment preserves coronary resistance artery function in rat cardiac allografts.
    Moien-Afshari F; Choy JC; McManus BM; Laher I
    J Heart Lung Transplant; 2004 Feb; 23(2):193-203. PubMed ID: 14761767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial loss and regeneration in a model of transplant arteriosclerosis.
    Gohra H; McDonald TO; Verrier ED; Aziz S
    Transplantation; 1995 Jul; 60(1):96-102. PubMed ID: 7624951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a novel inducible nitric oxide synthase inhibitor in prevention of rat chronic aortic rejections.
    Ouyang J; Xu D; Zhang X; Qi S; Ma A; Jiang W; Chida N; Sudo Y; Tamura K; Daloze P; Chen H
    Transplantation; 2005 May; 79(10):1386-92. PubMed ID: 15912108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Origin of neointimal endothelium and alpha-actin-positive smooth muscle cells in transplant arteriosclerosis.
    Hillebrands JL; Klatter FA; van den Hurk BM; Popa ER; Nieuwenhuis P; Rozing J
    J Clin Invest; 2001 Jun; 107(11):1411-22. PubMed ID: 11390423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular matrix composition and cellular mechanisms of transplant vasculopathy in rat aortic allografts.
    Religa P; Bojakowski K; Bojakowska M; Gaciong Z; Thyberg J; Hedin U
    Transplant Proc; 2002 Mar; 34(2):687-8. PubMed ID: 12009665
    [No Abstract]   [Full Text] [Related]  

  • 11. Arteriosclerosis in rat aortic allografts: early changes in endothelial integrity and smooth muscle phenotype.
    Bojakowski K; Religa P; Bojakowska M; Hedin U; Gaciong Z; Thyberg J
    Transplantation; 2000 Jul; 70(1):65-72. PubMed ID: 10919577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of combined rapamycin/cyclosporine on the changes in pro-fibrotic gene expression that occur during the development of allograft vasculopathy in rats, compared with cyclosporine or rapamycin in isolation.
    Murphy GJ; Bicknell GR; Nicholson ML
    Transpl Int; 2003 May; 16(5):347-53. PubMed ID: 12759727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrastructural evidence of early endothelial damage in coronary arteries of rat cardiac allografts.
    Lai JC; Tranfield EM; Walker DC; Dyck J; Kerjner A; Loo S; English D; Wong D; McDonald PC; Moghadasian MH; Wilson JE; McManus BM;
    J Heart Lung Transplant; 2003 Sep; 22(9):993-1004. PubMed ID: 12957609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced cyclooxygenase involvement in vascular endothelial function in rat renal transplantation.
    Smit-van Oosten A; Boonstra AH; Navis G; van Goor H; Buikema H
    Nephron Physiol; 2005; 100(2):p21-30. PubMed ID: 15795519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical characterization of inflammatory and proliferative events during chronic rejection in rat lung allografts.
    Lee AG; Wagner FM; Giaid A; Chen MF; Hamid Q; Serrick C; Shennib H
    Transplantation; 1997 Aug; 64(3):465-71. PubMed ID: 9275114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dichotomous effects of rosiglitazone in transplantation-induced systemic vasodilator dysfunction in rats.
    Onuta G; Hillebrands JL; Rienstra H; Boer MW; Klatter FA; Navis G; Rozing J; Roks AJ
    Transplantation; 2008 Feb; 85(4):582-8. PubMed ID: 18347538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoluminal smooth muscle cell seeding limits intimal hyperplasia.
    Gomes D; Louedec L; Plissonnier D; Dauge MC; Henin D; Osborne-Pellegrin M; Michel JB
    J Vasc Surg; 2001 Oct; 34(4):707-15. PubMed ID: 11668328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial T-cell activation required for transplant vasculopathy in retransplanted rat cardiac allografts.
    Tori M; Kitagawa-Sakakida S; Li Z; Izutani H; Horiguchi K; Ito T; Matsuda H; Shirakura R
    Transplantation; 2000 Sep; 70(5):737-46. PubMed ID: 11003350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of intimal hyperplasia in rat aortic allografts with cyclosporine.
    Stoltenberg RL; Geraghty J; Steele DM; Kennedy E; Hullett DA; Sollinger HW
    Transplantation; 1995 Nov; 60(9):993-8. PubMed ID: 7491707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low molecular weight fucoidan prevents neointimal hyperplasia after aortic allografting.
    Fréguin-Bouilland C; Alkhatib B; David N; Lallemand F; Henry JP; Godin M; Thuillez C; Plissonnier D
    Transplantation; 2007 May; 83(9):1234-41. PubMed ID: 17496541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.